The campaign for better prostate cancer awareness has provoked important questions about the lack of testing and screening. Why are men dying unnecessarily?

Top cancer specialists are urging men to look past the common symptoms of aging and recognize these critical warning signs. It’s often said that if you have your health, you have everything, and there ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

The idea is that most prostate cancers grow so slowly that they won't cause symptoms or shorten your lifespan, even if they’re left untreated. Prostate cancer treatments, on the other hand, can cause ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

March 6 (Reuters) - The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' (LNTH.O), opens new tab prostate cancer imaging agent, aimed at improving ‌scanning ...

Prostate cancer is the most common cancer to affect American men, besides skin cancer. The American Cancer Society estimates that 1 in 8 men will be diagnosed with prostate cancer at some point in ...

HDR-BT was significantly associated with increased biochemical failure risk and acute grade 2 or higher genitourinary adverse events. In men with intermediate-risk prostate cancer, stereotactic body ...

The 15-year OS rate was 60% among prostate brachytherapy recipients and 55% among EBRT recipients, indicating no significant difference between the arms. In prostate cancer, prostate brachytherapy (PB ...

Hormone therapy use and duration with post-operative radiotherapy for recurrent prostate cancer: An individual patient data meta-analysis. This is an ASCO Meeting Abstract from the 2026 ASCO ...

Bacillus Calmette-Guérin (BCG) and Beyond: Is Systemic Immunotherapy for BCG-Naïve Non–Muscle-Invasive Bladder Cancer Progress or Overreach? The classification of patients with prostate cancer, based ...

A pooled analysis of five prospective trials showed that stereotactic body radiotherapy (SBRT) was associated with a lower risk for biochemical failure over 10 years vs high-dose rate brachytherapy ...